Concomitant administration of prasugrel with cangrelor may lead to drug-drug interaction in patients undergoing PCI Dr. Kamal Kant Kohli24 Aug 2023 10:00 AM ISTUSA: Patients undergoing PCI (percutaneous coronary intervention) showed a drug-drug interaction with concomitant administration of prasugrel with...
Switching to cangrelor in CAD patients pretreated with ticagrelor safe without concerns for drug interactions: SWAP-5 Study Medha Baranwal9 Dec 2022 12:30 PM ISTUSA: The use of cangrelor in stable coronary artery disease (CAD) patients pretreated with ticagrelor results in enhanced platelet inhibition and the...
P2Y12 inhibitors Reduce Ischemic Events in First 2 hours Post PCI MD Bureau2 March 2022 9:30 AM ISTPatients undergoing percutaneous coronary intervention (PCI) are at risk of thrombotic complications including stent thrombosis causing myocardial...
MSN Labs gets USFDA nod for generic version of Cangrelor in India Ruchika Sharma17 Dec 2021 1:02 PM ISTHyderabad: Close on the heels of securing Drug Controller General of India's approval for CANREAL injection (generic version of Cangrelor) in India,...
Gland Pharma bags USFDA nod for Cangrelor for Injection Medical Dialogues Bureau11 Dec 2021 4:23 PM ISTHyderabad: Gland Pharma Limited has recently received a tentative approval from the United States Food and Drug Administration (US FDA) for Cangrelor...
FDA approves antiplatelet drug Kengreal based on Champion Phoenix Study Meghna A Singhania7 July 2015 12:26 PM ISTThe Medicines Company Announced FDA Approval of KENGREALâ„¢ (cangrelor) as an Adjunct to Percutaneous Coronary Intervention (PCI) for Reducing...
